Arthroscopy tech assessment
This article was originally published in The Gray Sheet
Executive Summary
CMS will determine by Jan. 8 the indications for which arthroscopic lavage and/or debridement are "reasonable and necessary" for treating osteoarthritis of the knee, based on a review of data published in The New England Journal of Medicine suggesting the procedures are no more effective than placebo (1"The Gray Sheet" Sept. 2, 2002, p. 6). In early December, the Veterans Administration plans to release an internal review of whether recent study findings warrant limited coverage of the procedure...
You may also be interested in...
VA Reviewing Coverage Of Arthroscopic Knee Surgery; NEJM Study Debated
The Veterans Administration plans to complete within the next 90 days an internal review of whether recent study findings warrant continued coverage of arthroscopic knee surgical procedures to alleviate pain and stiffness caused by osteoarthritis
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.